Insiders Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Market Closed - Nasdaq Other stock markets 21:00:00 26/06/2024 BST			After market 23:28:08
0.9247 ^USD	+7.94%		0.92	-0.51%

06-24	Akebia Therapeutics Names Erik Ostrowski CFO, CBO	MT
06-24	Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Akebia Therapeutics Names Erik Ostrowski CFO, CBO	06-24	MT
Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer	06-24	CI
Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Chief Financial Officer	06-24	CI
Akebia Therapeutics, Inc. Announces Management Changes, Effective March 22, 2024	03-15	CI
Akebia Therapeutics Names Nicholas Grund as Chief Commercial Officer	01-09	MT
Akebia Therapeutics Announces Appointment of Nicholas Grund as Chief Commercial Officer	01-09	CI
Akebia Therapeutics, Inc. Announces the Appointment of Richard C. Malabre as Chief Accounting Officer and Principal Accounting Officer	01-08	CI
Akebia Therapeutics, Inc. Announces Executive Changes	01/08/23	CI
Akebia Therapeutics Names Ellen Snow as Finance Chief	13/06/23	MT
Akebia Therapeutics, Inc. Announces Executive Changes	13/06/23	CI
Akebia Therapeutics, Inc. Announces Executive Changes	15/12/22	CI
Akebia Therapeutics, Inc. Appoints Ron Frieson to Its Nominating and Corporate Governance Committee	15/12/21	CI
Akebia Therapeutics, Inc. Appoints Ron Frieson to Board of Directors	01/11/21	CI
Immunic : Hires Patrick Walsh as Chief Business Officer	14/10/21	MT
Akebia Therapeutics, Inc. Announces Board Resignations	22/04/21	CI
Akebia Therapeutics Appoints LeAnne M. Zumwalt, Dialysis Industry Leader, to Board of Directors	18/02/21	CI
Akebia Therapeutics, Inc. Appoints Violetta Cotreau as Principal Accounting Officer	28/01/21	CI
Akebia Therapeutics Announces Executive Changes, Effective June 29, 2020	18/06/20	CI
Akebia Therapeutics, Inc. Announces Board Changes	07/04/20	CI
Akebia Therapeutics, Inc. Announces Resignation of Scott A. Canute as Class I Director	11/06/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Insiders

Filters